This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Handicapping the Q1 Earnings Season
by Sheraz Mian
The Q1 earnings season has gotten underway with earnings reports from 17 S&P 500 members.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Alliance, General Electric and Carnival
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Alliance, General Electric and Carnival
Stock Research Reports for Amgen, Berkshire & Walgreens
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Amgen, Inc. (AMGN) and Walgreens Boots Alliance Inc (WBA).
Will Fred???s Emerge a Winner from Walgreens-Rite Aid Merger?
by Zacks Equity Research
Discount retailer, Fred's Inc. (FRED) seems to have stolen the show and emerged as the big winner from the proposed merger between Rite Aid Corporation (RAD) and Walgreens Alliance, Inc. (WBA).
Walgreens Boots Grapples with Headwinds: Should You Dump?
by Zacks Equity Research
On Mar 8, we issued an updated research report on Illinois-based leading pharmacy-led, health and wellbeing enterprise Walgreens Boots Alliance, Inc. (WBA).
Fred's Dismal Comps Trend Continues, February Sales Fall
by Zacks Equity Research
Fred's Inc. (FRED) witnessed a soft start to fiscal 2017, with comps exhibiting a year-over-year decrease in the first month of the first quarter fiscal 2017.
Here's Why Rite Aid (RAD) is Tanking 17% Today
by Madeleine Johnson
On Monday, shares of retail drugstore chain Rite Aid (RAD) are tanking, down around 17% in afternoon trading after Walgreens Boots Alliance (WBA) said it would pay a lower price per share in its pending acquisition of the company
Zacks.com featured highlights: Extended Stay America, Walgreens Boots Alliance, Barnes & Noble, Universal Health Services and Greif
by Zacks Equity Research
Zacks.com featured highlights: Extended Stay America, Walgreens Boots Alliance, Barnes & Noble, Universal Health Services and Greif
Buy these 5 Low Leverage Stocks to Be Safe
by Zacks Equity Research
Considering the fact that debt ridden companies are more vulnerable at times of volatility, it is safe to avoid those for achieving optimal returns.
The Zacks Analyst Blog Highlights: Alibaba, Costco, Walgreens Boots, Biogen and PayPal
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alibaba, Costco, Walgreens Boots, Biogen and PayPal
Top Research Reports for Alibaba, Costco & Walgreens
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alibaba (BABA), Costco (COST) and Walgreens Boots (WBA).
Walgreens Teams Up with Fedex to Boost Retail Performance
by Zacks Equity Research
Walgreens Boots Alliance, Inc. (WBA) recently inked a multi-year partnership agreement with global express delivery services company FedEx Corporation (FDX).
Fred's Dismal Comps Trend Continues, December Sales Slip
by Zacks Equity Research
Fred's Inc. (FRED) saw a soft start to the fourth quarter of fiscal 2016, with comps demonstrating a year-over-year decrease in the first two months of the quarter.
Walgreens Boots (WBA) Tops Q1 Earnings, Misses on Revenues
by Zacks Equity Research
Currently, Walgreens Boots has a Zacks Rank #3 (Hold) but that could change following its mixed first quarter fiscal 2017 earnings report which has just released.
Rite Aid (RAD): Where Does the Stock Stand Post Earnings?
by Zacks Equity Research
Rite Aid (RAD) has seen its shares slide 2.4% since it released dismal third-quarter fiscal 2017 results.
Why You Should Hold onto Fred's (FRED) Stock in 2017
by Zacks Equity Research
Shares of Fred's Inc. (FRED) have displayed a promising gain of 19% in the past six months, outperforming the Zacks categorized Retail Wholesale industry.
What's in Store for Walgreens Boots (WBA) in Q1 Earnings?
by Zacks Equity Research
Walgreens Boots Alliance, Inc (WBA) is slated to release first-quarter 2017 results, before the market opens on Jan 5.
Fred's Inc's (FRED) Expansion Bodes Well: Should You Hold?
by Zacks Equity Research
'Every Cloud Has A Silver Lining' ??? the saying seems to ring true for discount retailer Fred's Inc. (FRED) at the moment.
Fred's to Expand Pharmacy Unit with Rite Aid Buyout, Stock Up
by Zacks Equity Research
Discount retailer Fred's Inc. (FRED) recently entered into an agreement with Rite Aid Corporation (RAD) and Walgreens Boots Alliance, Inc. (WBA).
Walgreens Boots and Rite Aid to Vend 865 Stores to Fred's
by Zacks Equity Research
Walgreens Boots Alliance Inc. (WBA) has moved forward with regards to the impending acquisition of Rite Aid by recently announcing a $950 million deal to sell 865 Rite Aid stores.
Jobless Claims, Draghi Speaks, More Q3 Earnings
by Mark Vickery
The finance-heavy early earnings season has shown some real progress in pushing out of a 5-month-long earnings recession.
Top Research Reports for September 12, 2016
by Mark Vickery
Today's must-read reports are for Qualcomm (QCOM), Priceline (PCLN) and Walgreens (WBA).
Top 7 Research Reports for July 8, 2016
by Sheraz Mian
Today's must-read reports are for Bristol-Myers (BMY), Lowe's (LOW) and Ingersoll (IR).
Big Data/Short Week Continues
by Mark Vickery
We're 2 days ahead of the big June Jobs Report. Until that time, we have plenty to chew on.
Weak Q3 Earnings Season Winding Down
by Sheraz Mian
The overall growth picture remains challenged, with companies struggling to beat lowered top-line expectations.